261 related articles for article (PubMed ID: 9404899)
1. The deadly quartet--the insulin resistance syndrome.
Opara JU; Levine JH
South Med J; 1997 Dec; 90(12):1162-8. PubMed ID: 9404899
[TBL] [Abstract][Full Text] [Related]
2. Type II diabetes and syndrome X. Pathogenesis and glycemic management.
Karam JH
Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069
[TBL] [Abstract][Full Text] [Related]
3. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
Pedersen O
Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
[TBL] [Abstract][Full Text] [Related]
4. [Pathophysiologic principles of metabolic syndrome. Consequences for early diagnosis and prevention].
Häring HU
Fortschr Med; 1992 Dec; 110(34):633-6. PubMed ID: 1483614
[TBL] [Abstract][Full Text] [Related]
5. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature.
Türkoglu C; Duman BS; Günay D; Cagatay P; Ozcan R; Büyükdevrim AS
Obes Surg; 2003 Oct; 13(5):699-705. PubMed ID: 14627463
[TBL] [Abstract][Full Text] [Related]
6. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.
Correia ML; Rahmouni K
Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484
[TBL] [Abstract][Full Text] [Related]
7. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
[TBL] [Abstract][Full Text] [Related]
9. [Syndrome X and general medicine].
Guillaume G; Moinie S; Bauler A
Rev Med Brux; 1995; 16(2):79-82. PubMed ID: 7784742
[TBL] [Abstract][Full Text] [Related]
10. [The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy].
Rett K; Wicklmayr M; Standl E
Wien Klin Wochenschr; 1994; 106(24):750-7. PubMed ID: 7846893
[TBL] [Abstract][Full Text] [Related]
11. [Lipid metabolism and insulin resistance--clinical aspects and pathobiochemistry].
Gries FA; Hübinger A
Wien Klin Wochenschr; 1994; 106(24):763-7. PubMed ID: 7846895
[TBL] [Abstract][Full Text] [Related]
12. [Metabolic syndrome and fatal quartet].
Standl E
Internist (Berl); 1996 Jul; 37(7):698-704. PubMed ID: 8766263
[No Abstract] [Full Text] [Related]
13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
14. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
Caballero AE
Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone and the metabolic syndrome.
Johannsson G; Bengtsson BA
J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
[TBL] [Abstract][Full Text] [Related]
17. [Hypertension and insulin resistance].
Voiculescu A; Kutkuhn B; Rösen P; Grabensee B
Wien Klin Wochenschr; 1997 Oct; 109(19):758-66. PubMed ID: 9441522
[TBL] [Abstract][Full Text] [Related]
18. Obesity and the metabolic syndrome in the elderly--a mini-review.
Lechleitner M
Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
[TBL] [Abstract][Full Text] [Related]
19. [Adipocytokins, obesity and development of type 2 diabetes].
Lacquemant C; Vasseur F; Leprêtre F; Froguel P
Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic medications: metabolic and cardiovascular risk.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
